Reaction
Pneumococcal Sepsis reporting signals
As of the last recalculation, Pneumococcal Sepsis appears in 643 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is CEFUROXIME (PRR 64.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cefuroxime | 22 | 64.5 | 64.6 |
| Piperacillin And Tazobactam | 24 | 63.1 | 63.2 |
| Gentamicin | 24 | 61.7 | 61.8 |
| Gentamicin Sulfate | 27 | 57.7 | 57.8 |
| Dornase Alfa | 28 | 48.3 | 48.4 |
| Dextrose | 18 | 45.5 | 45.6 |
| Dextrose Monohydrate | 18 | 44.8 | 44.9 |
| Piperacillin Sodium And Tazobactam Sodium | 24 | 41.1 | 41.1 |
| Piperacillin Sodium,Tazobactam Sodium | 30 | 38.4 | 38.4 |
| Meropenem | 34 | 36.2 | 36.2 |
| Melphalan | 19 | 27.8 | 27.9 |
| Propofol | 29 | 26.9 | 26.9 |
| Melphalan Hydrochloride | 20 | 26.6 | 26.6 |
| Ritonavir 100 Mg | 12 | 26.5 | 26.5 |
| Dolutegravir Sodium | 7 | 25.4 | 25.4 |
| Atazanavir | 11 | 25.2 | 25.2 |
| Thiotepa | 7 | 24.0 | 24.0 |
| Mesna Injection | 6 | 23.7 | 23.7 |
| Polatuzumab Vedotin | 7 | 23.5 | 23.5 |
| Mesna | 6 | 23.3 | 23.3 |
| Busulfan | 10 | 20.9 | 20.9 |
| Bendamustine Hcl | 9 | 19.0 | 19.0 |
| Carfilzomib | 16 | 18.8 | 18.8 |
| Fludarabine Phosphate | 22 | 18.7 | 18.7 |
| Daratumumab | 22 | 18.4 | 18.4 |
| Lamivudine Oral | 14 | 18.3 | 18.3 |
| Axicabtagene Ciloleucel | 5 | 16.5 | 16.5 |
| Bortezomib | 35 | 13.3 | 13.3 |
| Derma Foam Excel Hand Sanitizer | 3 | 12.2 | 12.2 |
| Ethanol | 3 | 12.2 | 12.2 |
| Ravulizumab | 5 | 12.1 | 12.1 |
| Sofosbuvir | 6 | 9.9 | 9.9 |
| Pomalidomide | 25 | 8.2 | 8.2 |
| Palivizumab | 3 | 6.3 | 6.3 |